Raw Ground Truth
Inclusion Criteria ComBaCaL-TwiC 1:Participant of the ComBaCaL cohort study (signed informed consent available)Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithmBP ≥140/90 mmHg at baselineInclusion criteria ComBaCaL-TwiC 2Participant of the ComBaCaL cohort study (signed informed consent available)Reporting intake of antihypertensive medicationBP<140/90 mmHg at baselineExclusion Criteria for both ComBaCaL-TwiC 1&2:Reported pregnancy (at baseline or during follow-up)
Raw Prediction
Inclusion Criteria ComBaCaL-TwiC 1:
- Participant of the ComBaCaL cohort study (signed informed consent available)
- Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithm
- BP ≥140/90 mmHg at baseline
Inclusion Criteria ComBaCaL-TwiC 2:
- Participant of the ComBaCaL cohort study (signed informed consent available)
- Reporting intake of antihypertensive medication
- BP <140/90 mmHg at baseline
Exclusion Criteria for both ComBaCaL-TwiC 1 & 2:
- Severe comorbidity with an estimated life-expectancy of less than one year
- Reported pregnancy (at baseline or during follow-up)
Processed Ground Truth
1. Inclusion Criteria ComBaCaL-TwiC 1:Participant of the ComBaCaL cohort study (signed informed consent available)Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithmBP ≥140/90 mmHg at baselineInclusion criteria ComBaCaL-TwiC 2Participant of the ComBaCaL cohort study (signed informed consent available)Reporting intake of antihypertensive medicationBP<140/90 mmHg at baselineExclusion Criteria for both ComBaCaL-TwiC 1&2:Reported pregnancy (at baseline or during follow-up)
Processed Prediction
1. Inclusion Criteria ComBaCaL-TwiC 1:
2. Participant of the ComBaCaL cohort study (signed informed consent available)
3. Living with aHT, defined as reporting intake of antihypertensive medication or being newly diagnosed during screening via standard diagnostic algorithm
4. BP ≥140/90 mmHg at baseline
5. Inclusion Criteria ComBaCaL-TwiC 2:
6. Participant of the ComBaCaL cohort study (signed informed consent available)
7. Reporting intake of antihypertensive medication
8. BP <140/90 mmHg at baseline
9. Exclusion Criteria for both ComBaCaL-TwiC 1 & 2:
10. Severe comorbidity with an estimated life-expectancy of less than one year
11. Reported pregnancy (at baseline or during follow-up)